IL13 and asthma: We estimated the time-related variation in serum periostin levels in adults with asthma receiving maintenance ICS and long-acting beta agonist (LABA) therapy; the clinical population in which serum periostin levels are a predictor of responsiveness to monoclonal antibody therapy directed against IL-4, IL-13 and IgE [9–11].